US Stock MarketDetailed Quotes
OSTX OS Therapies
- 4.000
- 0.0000.00%
Close Jun 26 16:00 ET
82.39MMarket Cap-10928P/E (TTM)
0.000High0.000Low0Volume0.000Open4.000Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)20.60MShares0.00052wk High-3.23P/B8.00MFloat Cap0.00052wk Low--Dividend TTM2.00MShs Float0.000Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low--Avg Price1Lot Size
OS Therapies Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||
| Cash flow from continuing operating activities | -49.87%-641.73K | 20.71%-3.01M | 55.44%-428.19K | 13.86%-3.79M | -960.91K | -4.4M |
| Net income from continuing operations | 21.01%-1.46M | -24.57%-7.79M | -35.56%-1.85M | 15.71%-6.25M | ---1.36M | ---7.42M |
| Depreciation and amortization | 595.00%695 | 424.22%4.22K | --100 | 0.00%805 | --0 | --805 |
| Other non cash items | -21.03%578.74K | 82.51%2.76M | 194.20%732.84K | -38.00%1.51M | --249.09K | --2.44M |
| Change In working capital | -65.32%237.83K | 112.94%2.02M | 349.68%685.84K | 64.85%947.33K | --152.52K | --574.67K |
| -Change in payables and accrued expense | -65.32%237.83K | 112.94%2.02M | 349.68%685.84K | 64.85%947.33K | --152.52K | --574.67K |
| Cash from discontinued investing activities | ||||||
| Operating cash flow | -49.87%-641.73K | 20.71%-3.01M | 55.44%-428.19K | 13.86%-3.79M | ---960.91K | ---4.4M |
| Investing cash flow | ||||||
| Cash flow from continuing investing activities | 0 | -99.50%1.15K | 1.15K | 15.17%230.88K | 0 | 200.47K |
| Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | ---11.93K |
| Net other investing changes | ---- | -99.50%1.15K | --1.15K | 8.70%230.88K | ---- | --212.41K |
| Cash from discontinued investing activities | ||||||
| Investing cash flow | --0 | -99.50%1.15K | --1.15K | 15.17%230.88K | --0 | --200.47K |
| Financing cash flow | ||||||
| Cash flow from continuing financing activities | 15.10%702.98K | -21.33%2.87M | -33.97%610.78K | 19.74%3.65M | 925K | 3.05M |
| Net issuance payments of debt | 9.81%851K | -17.44%3.16M | -16.22%775K | 29.63%3.82M | --925K | --2.95M |
| Net other financing activities | 9.87%-148.02K | -65.20%-284.18K | ---164.23K | -272.02%-172.02K | ---- | --100K |
| Cash from discontinued financing activities | ||||||
| Financing cash flow | 15.10%702.98K | -21.33%2.87M | -33.97%610.78K | 19.74%3.65M | --925K | --3.05M |
| Net cash flow | ||||||
| Beginning cash position | -77.27%38.98K | 112.26%171.48K | 112.26%171.48K | -93.45%80.79K | --80.79K | --1.23M |
| Current changes in cash | -66.66%61.25K | -246.10%-132.5K | 611.68%183.73K | 107.87%90.69K | ---35.91K | ---1.15M |
| End cash Position | -71.78%100.23K | -77.27%38.98K | 691.48%355.21K | 112.26%171.48K | --44.88K | --80.79K |
| Free cash flow | -49.87%-641.73K | 20.71%-3.01M | 55.44%-428.19K | 14.09%-3.79M | ---960.91K | ---4.41M |
| Currency Unit | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg